4 Stocks That Could Be a Blast ( RDN, MW, NAV, OREX )

Los Angelas, CA -- (SBWIRE) -- 09/07/2012 -- Radian Group Inc. (NYSE:RDN) reported EPS of -1.711. For the Current Fiscal year, the company is expected to report EPS of -3.43. For the Next Quarter and Next Year, the company is expected to report EPS of -0.59 and -0.46 respectively. At Current Market Price, RDN is in distance of +28.70% from its 50-day Moving Average price of $3.1391 and +26.32% from its 200-day Moving Average price of $3.1981.Radian Group Inc. 18.2% HIGHER; unt released data for primary mortgage insurance delinquencies for August 2012. Beginning Primary Delinquent Inventory of 91,012 fell to 94,823 by the end of August.

Get a free trend analysis on RDN Click Here

Men's Wearhouse, (NYSE:MW) is very active today and traded between $34.82 - 38.0825 with total traded volume of 3847156 shares. At a current price of 37.79, MW is +5.95 - +18.69% from the previous close of $31.84. Moreover, At Current Market Price, MW is in distance of +28.98% from its 50-day Moving Average price of $29.2994 and +12.67% from its 200-day Moving Average price of $33.5398. In earnings news, shares of Men's Wearhouse surged 18.8% after the men's suits retailer said its fiscal second-quarter profit rose to $59.4 million, or $1.15 per share, from $57.1 million, or $1.09 per share, a year earlier. Revenue rose 1% to $662.3 million, while same-store sales rose 4.4%. Analysts had expected a profit of $1.12 per share on revenue of $662.9 million.

Sign up here for our full analysis Click Here

Navistar Internat (NYSE:NAV) is +3.56 - +17.44% from the previous close of $20.41. It traded between $21.11 - 24.24 with total traded volume of 7924962 shares. Keep a close eye on NAV, as the stock has been showing unusual moves over the past weeks. At Current market price, NAV has recovered +21.12% from its 52-week Low of 19.79 and has Pulled back -50.25% from its 52-week high of 48.18. Shares of truck maker Navistar International surged 7% to $21.76 Thursday morning. Navistar reported an $84 million profit for the quarter ended July 31, which exceeded Wall Street's expectations. Navistar also said it was reviewing "all of its non-core businesses" to help shore up profitability. The company further said it was cutting costs through employee buyouts and workforce reductions.

Get a breakout signals For Free Click Here

Orexigen Therapeutics (NGM:OREX) is very active today and traded between $5.25 - 5.86 with total traded volume of 10009369 shares. At a current price of 5.73, OREX is +0.82 - +16.70% from the previous close of $4.91. Moreover, At Current Market Price, OREX is in distance of +21.73% from its 50-day Moving Average price of $4.7071 and +32.56% from its 200-day Moving Average price of $4.3227. The company said the safety study for its obesity drug Contrave has recruited more than 4,500 patients and is now on target to close enrollment by the end of the year. Shares of Orexigen Therapeutics OREX +16.70% soared 19% to $5.82 on Thursday after Credit Suisse initiated coverage of the stock with an outperform rating and price target of $13. The stock has climbed 31% over the past 30 days and rocketed 262% since the beginning of the year, fueled by speculation over if and when its diet drug Contrave will be approved by U.S. regulators.

Sign up for our free analysis

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com